{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Inherited white matter disorders",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_clonazepam",
          "name": "Clonazepam"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_valproic_acid",
          "name": "Valproic acid"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_gabapentin",
          "name": "Gabapentin"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_carbamazepine",
          "name": "Carbamazepine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_phenytoin",
          "name": "Phenytoin"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_topiramate",
          "name": "Topiramate"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_lamotrigine",
          "name": "Lamotrigine"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_lacosamide",
          "name": "Lacosamide"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_oxcarbazepine",
          "name": "Oxcarbazepine"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_divalproex_sodium",
          "name": "Divalproex sodium"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_baclofen",
          "name": "Baclofen"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_zonisamide",
          "name": "Zonisamide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot",
          "type": "Target",
          "label": "Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp1",
          "type": "Pathway",
          "label": "Risk Pathway for CNS Depression",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv1",
          "type": "Phenotype",
          "label": "Adverse CNS Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp2",
          "type": "Pathway",
          "label": "Risk Pathway for Teratogenic Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv2",
          "type": "Phenotype",
          "label": "Adverse Developmental Outcomes",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_clonazepam",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致中枢神经系统抑制"
        },
        {
          "source": "drug_valproic_acid",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "与神经发育影响相关风险"
        },
        {
          "source": "drug_gabapentin",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "具有潜在的离靶效应"
        },
        {
          "source": "n_ot",
          "target": "n_rp1",
          "relation": "involved_in",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "影响中枢神经系统的功能"
        },
        {
          "source": "n_rp1",
          "target": "n_adv1",
          "relation": "causes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "可能导致不良的中枢神经综合表现"
        },
        {
          "source": "n_ot",
          "target": "n_rp2",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "与发育风险相关"
        },
        {
          "source": "n_rp2",
          "target": "n_adv2",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在导致不良的发育结果"
        },
        {
          "source": "n_adv1",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "中枢神经系统不良影响抵消视疗效"
        },
        {
          "source": "n_adv2",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "发育不良影响反驳益处假设"
        }
      ],
      "merge": [],
      "set_weights": [],
      "conflict_hotspots": [
        {
          "topic": "CNS depression vs therapeutic benefit",
          "pro_nodes": [
            "n_adv1"
          ],
          "con_nodes": [
            "H1"
          ],
          "note": "短期缓解与长期不良影响之间的矛盾"
        },
        {
          "topic": "teratogenic risk vs safety in pregnancy",
          "pro_nodes": [
            "n_adv2"
          ],
          "con_nodes": [
            "H2"
          ],
          "note": "可能的发育风险与治疗安全性的冲突"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "存在潜在的中枢神经系统抑制风险，可能影响药物疗效",
        "confidence": "high"
      },
      {
        "id": "K2",
        "text": "可能导致发育不良的机制风险链，难以支持临床应用",
        "confidence": "high"
      }
    ],
    "assumptions_challenged": [
      "药物对中枢神经的作用是否满足疾病需求",
      "药物在妊娠中的安全性是否得到充分验证"
    ],
    "falsification_tests": [
      "药物在使用于祖传白质疾病时是否存有改良长期结局的证据？",
      "是否有临床数据能支持其在怀孕期间的安全性？"
    ],
    "next_focus_for_pi": [
      "要求 Proponent 提供支持长期安全性的临床数据",
      "重新评估风险等级和可能的对冲机制"
    ]
  }
}